Sirdupla 25 microgram/125 microgram per metered dose pressurised inhalation, suspension Írland - enska - HPRA (Health Products Regulatory Authority)

sirdupla 25 microgram/125 microgram per metered dose pressurised inhalation, suspension

viatris limited - salmeterol xinafoate; fluticasone propionate - pressurised inhalation, suspension - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salmeterol and fluticasone

Sirdupla 25 microgram/250 microgram per metered dose pressurised inhalation, suspension Írland - enska - HPRA (Health Products Regulatory Authority)

sirdupla 25 microgram/250 microgram per metered dose pressurised inhalation, suspension

viatris limited - salmeterol xinafoate; fluticasone propionate - pressurised inhalation, suspension - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salmeterol and fluticasone

FLUTIFORM® PRESSURISED INHALATION SUSPENSION 50 MICROGRAM5 MICROGRAM PER ACTUATION Singapúr - enska - HSA (Health Sciences Authority)

flutiform® pressurised inhalation suspension 50 microgram5 microgram per actuation

mundipharma pharmaceuticals pte. ltd. - fluticasone propionate; formoterol fumarate dihydrate - aerosol, metered - 50 mcg/actuation - fluticasone propionate 50 mcg/actuation; formoterol fumarate dihydrate 5 mcg/actuation

FLUTIFORM® PRESSURISED INHALATION SUSPENSION 125 MICROGRAM5 MICROGRAM PER ACTUATION Singapúr - enska - HSA (Health Sciences Authority)

flutiform® pressurised inhalation suspension 125 microgram5 microgram per actuation

mundipharma pharmaceuticals pte. ltd. - fluticasone propionate; formoterol fumarate dihydrate - aerosol, metered - 125 mcg/actuation - fluticasone propionate 125 mcg/actuation; formoterol fumarate dihydrate 5 mcg/actuation

FLUTIFORM® PRESSURISED INHALATION SUSPENSION 250 MICROGRAM10 MICROGRAM PER ACTUATION Singapúr - enska - HSA (Health Sciences Authority)

flutiform® pressurised inhalation suspension 250 microgram10 microgram per actuation

mundipharma pharmaceuticals pte. ltd. - fluticasone propionate; formoterol fumarate dihydrate - aerosol, metered - 250 mcg/actuation - fluticasone propionate 250 mcg/actuation; formoterol fumarate dihydrate 10 mcg/actuation

Fostair 200 microgram/6 microgram per actuation pressurised inhalation solution Írland - enska - HPRA (Health Products Regulatory Authority)

fostair 200 microgram/6 microgram per actuation pressurised inhalation solution

chiesi limited - beclometasone dipropionate anhydrous; formoterol fumarate dihydrate - pressurised inhalation, solution - 200/6 mcg/acutuation - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; formoterol and beclometasone

Zerseos 0.5 mg/2.5 mg per 2.5 ml nebuliser solution Írland - enska - HPRA (Health Products Regulatory Authority)

zerseos 0.5 mg/2.5 mg per 2.5 ml nebuliser solution

cipla europe nv - ipratropium bromide monohydrate; salbutamol sulfate - nebuliser solution - 0.5mg/2.5 milligram(s) - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salbutamol and sodium cromoglicate

Fostair 200 microgram/6 microgram per actuation pressurised inhalation solution Írland - enska - HPRA (Health Products Regulatory Authority)

fostair 200 microgram/6 microgram per actuation pressurised inhalation solution

chiesi farmaceutici s.p.a. - beclometasone dipropionate anhydrous; formoterol fumarate dihydrate - pressurised inhalation, solution - 200/6 µg/µg - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; formoterol and beclometasone

Fostair Nexthaler 100 micrograms/6 micrograms per metered dose inhalation powder Írland - enska - HPRA (Health Products Regulatory Authority)

fostair nexthaler 100 micrograms/6 micrograms per metered dose inhalation powder

chiesi farmaceutici s.p.a. - beclometasone dipropionate anhydrous; formoterol fumarate dihydrate - inhalation powder - 100/6 µg/µg - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; formoterol and beclometasone

Bemrist Breezhaler Evrópusambandið - enska - EMA (European Medicines Agency)

bemrist breezhaler

novartis europharm limited  - indacaterol, mometasone furoate - asthma - drugs for obstructive airway diseases, - bemrist breezhaler is indicated as a maintenance   treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.